Division of Organ Transplantation

Our Division

Welcome to the Division of Organ Transplantation of the Northwestern University Feinberg School of Medicine. Founded in 1964, Northwestern University's transplantation program is the longest-standing program in the Chicago area. Under the direction of Michael Abecassis, MD, MBA, the Division of Organ Transplantation has established a national and international reputation for excellence and innovation in research, education, and patient care through Feinberg’s clinical affiliates.

Learn more about our work via the links below.

Education
Learn about our contributions to the education of future leaders in our field
Research
Discover our areas of focus in research
Patient Care
Connect with our affiliated care sites
Faculty
Meet our faculty members
About Us
Connect with our office; meet our chief

Meet our Faculty

Sanjay Kulkarni, MD

Adjunct Associate Professor of Surgery (Organ Transplantation)

See All Faculty

Message from the Chief

Read message from the Chief, Michael M. I. Abecassis, MD/MBA

Events

Sep
24
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Sep
25
3rd Annual CMV P01 Symposium: Cytomegalovirus Latency and Reactivation
12:00 PM - 5:30 PM
Sep
25
3rd Annual CMV P01 Symposium: Cytomegalovirus Latency and Reactivation!
12:00 PM - 4:30 PM
Oct
1
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Oct
8
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Oct
15
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Oct
22
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Oct
29
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Nov
5
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Nov
12
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Nov
19
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Nov
26
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Dec
3
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Dec
10
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Dec
17
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM
Dec
24
NUTORC - Transplant Outcomes Research
9:00 AM - 10:00 AM

More Events

News

12.19.2017Congratulations Dr. Wertheim
12.19.2017Congratulations Dr. Leventhal

Recent Publications

HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details.
Tambur AR.
Front Immunol. 2018 Aug 31;9:2010. doi: 10.3389/fimmu.2018.02010. eCollection 2018.
Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model.
Figini M, Wang X, Lyu T, Su Z, Wang B, Sun C, Shangguan J, Pan L, Zhou K, Ma Q, Yaghmai V, Procissi D, Larson AC, …
Am J Cancer Res. 2018 Aug 1;8(8):1615-1623. eCollection 2018.
Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency.
Forte E, Swaminathan S, Schroeder MW, Kim JY, Terhune SS, Hummel M.
MBio. 2018 Sep 11;9(5). pii: e01560-18. doi: 10.1128/mBio.01560-18.
MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study.
Ali R, Gabr A, Mouli SK, Kallini JR, Riaz A, Mora R, Lewandowski RJ, Hohlastos E, Casalino DD, Hofer MD, Hamoui N, …
Abdom Radiol (NY). 2018 Sep 8. doi: 10.1007/s00261-018-1757-z. [Epub ahead of print]
Patient-reported outcome measures are necessary for guiding treatment of keratinocyte cancer, a chronic disease.
Alam M.
Br J Dermatol. 2018 Aug;179(2):258-259. doi: 10.1111/bjd.16835. No abstract available.
Self-reported Patient Motivations for Seeking Cosmetic Procedures.
Maisel A, Waldman A, Furlan K, Weil A, Sacotte K, Lazaroff JM, Lin K, Aranzazu D, Avram MM, Bell A, Cartee TV, …
JAMA Dermatol. 2018 Aug 15. doi: 10.1001/jamadermatol.2018.2357. [Epub ahead of print]
Receptor Tyrosine Kinase MerTK Suppresses an Allogenic Type I IFN Response to Promote Transplant Tolerance.
Zhang L, DeBerge M, Wang J, Dangi A, Zhang X, Schroth S, Zhang Z, Thorp E, Luo X.
Am J Transplant. 2018 Aug 22. doi: 10.1111/ajt.15087. [Epub ahead of print]
Injection technique in neurotoxins and fillers: Indications, products, and outcomes.
Alam M, Tung R.
J Am Acad Dermatol. 2018 Sep;79(3):423-435. doi: 10.1016/j.jaad.2018.01.037. Review.
Injection technique in neurotoxins and fillers: Planning and basic technique.
Alam M, Tung R.
J Am Acad Dermatol. 2018 Sep;79(3):407-419. doi: 10.1016/j.jaad.2018.01.034. Review.
Complex bile duct network formation within liver decellularized extracellular matrix hydrogels.
Lewis PL, Su J, Yan M, Meng F, Glaser SS, Alpini GD, Green RM, Sosa-Pineda B, Shah RN.
Sci Rep. 2018 Aug 15;8(1):12220. doi: 10.1038/s41598-018-30433-6.
Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial.
Chauhan N, Bukovcan J, Boucher E, Cosgrove D, Edeline J, Hamilton B, Kulik L, Master F, Salem R.
JMIR Res Protoc. 2018 Aug 15;7(8):e11234. doi: 10.2196/11234.
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.
Chan C, Schiano T, Agudelo E, Paul Haydek J, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J.
Am J Transplant. 2018 Aug 3. doi: 10.1111/ajt.15053. [Epub ahead of print]
Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma.
Wang L, Ma Q, Li D, Mu S, Li Y, Wang Y, Shi P, Yu H, Gao C, Guo K, Zhang Z.
Pathol Res Pract. 2018 Sep;214(9):1309-1314. doi: 10.1016/j.prp.2018.02.016. Epub 2018 Feb 21.
Effect of Stress Ball Use or Hand-holding on Anxiety During Skin Cancer Excision: A Randomized Clinical Trial.
Yanes AF, Weil A, Furlan KC, Poon E, Alam M.
JAMA Dermatol. 2018 Sep 1;154(9):1045-1049. doi: 10.1001/jamadermatol.2018.1783.
Apoptotic cell-based therapies for promoting transplantation tolerance.
Dangi A, Yu S, Luo X.
Curr Opin Organ Transplant. 2018 Oct;23(5):552-558. doi: 10.1097/MOT.0000000000000562.
Video education to improve recognition of common benign and malignant cutaneous lesions and skin cancer prevention in the public.
Lenczowski E, Tung-Hahn E, Higareda J, McCormick C, Markoff T, Arffa M, Poon E, Lee K, Alam M.
Int J Womens Dermatol. 2017 Nov 27;4(2):80-82. doi: 10.1016/j.ijwd.2017.10.005. eCollection 2018 Jun.
Quantitative measurement of breast carcinoma fibrosis for the prediction in the risk of bone metastasis.
Sun C, Wang B, Li J, Shangguan J, Figini M, Zhou K, Pan L, Ma Q, Zhang Z.
Am J Transl Res. 2018 Jun 15;10(6):1852-1859. eCollection 2018.
Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.
Friedewald JJ,… Friedewald JJ … Kandpal M …
Am J Transplant. 2018 Jul 9. doi: 10.1111/ajt.15011. [Epub ahead of print]
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.
Pinelli DF,… Friedewald JJ … Tambur AR …
Am J Transplant. 2018 Jul 7. doi: 10.1111/ajt.15007. [Epub ahead of print]

View full list in PubMed